1. Home
  2. LINC vs PHAR Comparison

LINC vs PHAR Comparison

Compare LINC & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lincoln Educational Services Corporation

LINC

Lincoln Educational Services Corporation

HOLD

Current Price

$40.94

Market Cap

1.2B

Sector

Real Estate

ML Signal

HOLD

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

HOLD

Current Price

$16.46

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LINC
PHAR
Founded
1946
1988
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
2005
2020

Fundamental Metrics

Financial Performance
Metric
LINC
PHAR
Price
$40.94
$16.46
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
3
Target Price
$45.00
$38.33
AVG Volume (30 Days)
310.3K
6.5K
Earning Date
05-11-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
100.00
N/A
EPS
0.64
N/A
Revenue
$261,853,000.00
N/A
Revenue This Year
$15.16
$10.04
Revenue Next Year
$9.02
$2.51
P/E Ratio
$64.10
$3,041.22
Revenue Growth
32.98
N/A
52 Week Low
$17.29
$8.60
52 Week High
$42.85
$21.34

Technical Indicators

Market Signals
Indicator
LINC
PHAR
Relative Strength Index (RSI) 56.03 46.37
Support Level $38.92 $15.96
Resistance Level $42.69 $17.28
Average True Range (ATR) 1.57 0.37
MACD -0.14 -0.11
Stochastic Oscillator 53.81 5.11

Price Performance

Historical Comparison
LINC
PHAR

About LINC Lincoln Educational Services Corporation

Lincoln Educational Services Corp provides diversified career-oriented post-secondary education to high school graduates and working adults. The company offers programs in automotive technology, skilled trades, healthcare services, hospitality services, and business and information technology. Its reportable segments include: Campus Operations and Transitional. The majority of the revenue is generated from the Campus Operations segment, which includes all campuses that are continuing in operation and contribute to the company's core operations and performance.

About PHAR Pharming Group N.V.

Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.

Share on Social Networks: